License Grant. Subject to the terms of this Agreement, including Section 5.2, Dynavax hereby grants to Purchaser a worldwide, fully-paid up, royalty-free, non-exclusive, non-transferable (except in connection with a permitted assignment of this Agreement in accordance with Section 11.6), limited license, with the right to grant sublicenses, under the Dynavax Technology solely to develop, make, have made, use, sell, have sold, offer for sale, import and otherwise commercially exploit Products in the Field; provided, however, that the foregoing license to make and have made Products is limited to the right to make or have made Products using the CpG Material supplied by Dynavax pursuant to this Agreement, and specifically excludes any license or other right to make or have made the CpG Adjuvant or CpG Material. The license granted to Purchaser in this Section 5.1 includes the right to sublicense (through multiple tiers) to Purchaser’s Affiliates and to Purchaser’s or Purchaser’s Affiliates’ licensees or distributors of Products and any other companies that work with Purchaser or Affiliate in connection with the manufacture, supply, and other commercialization of the Products and Purchaser shall be responsible for the compliance of any sublicensees with this Agreement. Purchaser shall not have any other right to grant sublicenses under the license granted to Purchaser in this Section 5.1; provided, however, that Purchaser may contract with Third Party CMOs for the manufacture, on Purchaser’s behalf, of Products using the CpG Material supplied under this Agreement, and such contracting shall not be considered a sublicense. The foregoing license shall not be construed to obligate Dynavax to disclose or transfer to Purchaser any Dynavax Technology.

#[[Peraso:Organization]] hereby grants to [[Intel:Organization]] an unlimited, irrevocable, perpetual, non-terminable, fully paid up, royalty-free, freely transferrable (as set forth in Section 16.3 below), freely sublicensable (through multiple tiers of sublicensees), exclusive (even as to [[Peraso:Organization]], as set forth in [Section 2.2] below) right and license, under all of [[Peraso:Organization]]’s applicable Intellectual Property Rights in and to the Licensed Technology, to develop, make, make for others, have made, perform, have performed, perform for others, use, operate, sell, offer for sale, import, and export products embodying or using the Licensed Technology, and to otherwise freely commercialize and exploit the Licensed Technology in the Territory, as [[Intel:Organization]] deems fit in its sole and absolute discretion.

License Grant. Subject to the terms and conditions of this Agreement, including Section 8.3, AzurRx hereby grants to FWB a worldwide, non-exclusive, royalty-free, perpetual, irrevocable license under the Program IP and any other intellectual property owned by AzurRx and incorporated into the Product for the Exploitation of such Product during the Term, solely for use outside the Field in the Territory, and if this Agreement is terminated rather than expires, then such license shall be for the Exploitation of the Product both inside and outside the Field, in the Territory.

License Grant. Subject to the terms of this Agreement, ​, [[Agenus:Organization]] hereby grants Betta a royalty-bearing, non-transferable (except in accordance with [Section 14.3]), sublicenseable (subject to Section 2.5) license or sublicense, as applicable, under the Licensed IP solely to Develop, Manufacture and Commercialize Licensed Products in the Field and in the Territory (the “License”). Subject to Section 2.2 and Section 2.3, the License will be # exclusive (even as to [[Agenus:Organization]] and its Affiliates) with respect to the Licensed Patent Rights and the Licensed Know-How that are exclusively licensed to [[Agenus:Organization]] or owned by [[Agenus:Organization]], and # non-exclusive with respect to the Licensed Patent Rights and Licensed Know-How that are non-exclusively licensed to [[Agenus:Organization]].

License Grant. Subject to the reservations of rights set forth in Paragraph 2.2, BCM hereby grants to LICENSEE an exclusive, worldwide, sublicensable license under the Patent Rights and Subject Technology, to make, have made, use, market, sell, offer to sell, lease and import Licensed Products in the Field.

License Grant. Subject to the terms and conditions of this Agreement, including Merck’s retained rights under [Section 2.3], Merck hereby grants to Licensee an exclusive (even as to Merck), sub-licensable (subject to the obligations and restrictions in [Section 2.5]), royalty-bearing license under the Merck Know-How, Compound Patent Rights, and Merck’s interest in any solely or jointly owned Program IP to Develop, make, have made, use, import, export, Commercialize, sell, offer for sale, and market the Licensed Compound and Licensed Product in the Field in the Territory.

License Grant. Subject to the terms and conditions of this Agreement, Licensor hereby grants to Company an exclusive (even as to Licensor, subject to any Definitive Agreement, if applicable), worldwide, fully paid-up, royalty-free license, with the right to sublicense through multiple tiers of sublicense, under the Licensed Technology, to research, develop, make, have made, use, sell, offer for sale, have sold and import any Product in the Field. For the avoidance of doubt, subject to the terms and conditions of this Agreement, Company shall be free to use, disclose, reproduce, license, and otherwise distribute and exploit the Licensed Technology with respect to any Product in the Field as it sees fit, without any obligation or duty to account to Licensor.

License Grant. Subject to the terms and conditions of this Agreement, including [Section 8.3, FWB] hereby grants to AzurRx an exclusive (even as to FWB and its Affiliates), non-transferable (except as permitted under [Section 16.2]), sublicensable through multiple tiers (solely in accordance with Section 8.1.2) license under: # the FWB Background IP, # FWB’s rights to any Program IP, and # any other intellectual property Controlled by FWB as of the Effective Date or at any time during the Term and necessary or reasonably useful to Exploit the Existing Product (collectively the “Licensed IP”), in each case ((i) - (iii)), to Develop and have Developed, make, have made, use, sell, have sold, import, export and Exploit the Product in the Field in the Territory.

License Grant. Urovant hereby grants to Sunovion during the Term a non-exclusive license, with the right to grant sublicenses, under any intellectual property rights owned or controlled by Urovant in the Territory, including with respect to the Materials, Work Product and IP solely to enable Sunovion to perform the Co-Promotion Activities.

License Grant. Subject to the limitations and other terms and conditions set forth in this Agreement including those reserved by Institute in [Section 2.5(a)], Institute hereby grants to Licensee an exclusive, royalty-bearing, sublicenseable (in accordance with [Article 3]) license in, to and under # the Patent Rights and the Know-How Rights, and # Institute’s interest in any patents and patent applications owned jointly by Licensee and Institute, to make, use, Sell, offer for Sale and import Licensed Products, and to practice Licensed Methods, in each case with respect to # Allogeneic CTL Products in the Territory in the Licensed Field, # solely with respect to HPV-Specific CTL Products, EBV-Specific Autologous Products, and Autologous CTL Products in the Licensed Field, and # solely following ​ arising from the ​.